We are live on ! Find out more
CVS icon

CVS Health

1,210 hedge funds and large institutions have $71.4B invested in CVS Health in 2013 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 424 increasing their positions, 492 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 157 | Existing positions closed: 65

65% more funds holding in top 10

Funds holding in top 10: 83137 (+54)

22% more capital invested

Capital invested by funds: $58.3B → $71.4B (+$13.1B)

7% more funds holding

Funds holding: 1,1291,210 (+81)

9% more call options, than puts

Call options by funds: $355M | Put options by funds: $326M

0.98% more ownership

Funds ownership: 82.97%83.95% (+0.98%)

14% less repeat investments, than reductions

Existing positions increased: 424 | Existing positions reduced: 492

Holders
1,210
Holders Change
+81
Holders Change %
+7.17%
% of All Funds
35.12%
Holding in Top 10
137
Holding in Top 10 Change
+54
Holding in Top 10 Change %
+65.06%
% of All Funds
3.98%
New
157
Increased
424
Reduced
492
Closed
65
Calls
$355M
Puts
$326M
Net Calls
+$29.3M
Net Calls Change
+$78.1M
Name Holding Trade Value Shares
Change
Change in
Stake
ANRIA
801
American National Registered Investment Advisor
Texas
$1.33M -$6.42K -100 -0.5%
AIM
802
Acuity Investment Management
Ontario, Canada
$1.32M -$2.24M -34,900 -65%
ACM
803
Argyle Capital Management
Pennsylvania
$1.32M -$75K -1,167 -6%
NC
804
Northpointe Capital
Michigan
$1.32M -$28.3K -440 -2%
TSW
805
Thompson Siegel & Walmsley
Virginia
$1.32M -$64.3K -1,000 -5%
AWM
806
Altavista Wealth Management
North Carolina
$1.32M +$177K +2,748 +18%
PSC
807
Prentiss Smith & Co
Vermont
$1.32M -$413K -6,425 -26%
LOCB
808
Lombard Odier & Cie (Bahamas)
Bahamas
$1.31M +$1.18M +18,370 New
LJAC
809
L.J. Altfest & Co
New York
$1.31M +$1.18M +18,350 New
CWM
810
Concert Wealth Management
California
$1.3M +$187K +2,918 +19%
AI
811
Atria Investments
North Carolina
$1.29M +$67.9K +1,057 +6%
IIM
812
Ivory Investment Management
New York
$1.28M +$25.6K +399 +2%
MWNA
813
Marshall Wace North America
New York
$1.26M +$1.14M +17,675 New
MC
814
Middleton & Co
Massachusetts
$1.26M +$274K +4,260 +32%
TNBTD
815
Trustmark National Bank Trust Department
Mississippi
$1.26M +$53.8K +837 +5%
IIM
816
Intact Investment Management
Quebec, Canada
$1.25M -$77.1K -1,200 -6%
CK
817
Carnick & Kubik
Colorado
$1.24M -$52K -810 -4%
PCM
818
Perkins Capital Management
Minnesota
$1.23M +$38.6K +600 +4%
MNBTD
819
Moody National Bank Trust Division
Texas
$1.23M -$6.42K -100 -0.6%
FCB
820
First Citizens Bancorporation
South Carolina
$1.23M -$103K -1,605 -9%
Bank of Nova Scotia
821
Bank of Nova Scotia
Ontario, Canada
$1.22M -$1.49M -23,115 -58%
KS
822
Karpas Strategies
Connecticut
$1.21M
BVDMP
823
Bedrijfstakpensioenfonds Voor De Media PNO
Netherlands
$1.21M
BOS
824
Bank of Stockton
California
$1.2M -$15.1K -235 -1%
GA
825
Geneva Advisors
Illinois
$1.2M +$9.7K +151 +0.9%

CVS Hedge Fund Activity: Q4 2013 in Review

1,210 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2013, worth a combined $71.4B — up 22% from $58.3B a quarter earlier.

Buyers outnumbered sellers: 157 funds opened new CVS positions and 65 closed out — a net gain of 92 holders — while 424 added to existing stakes and 492 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $207M. The largest seller was Fidelity Investments, cutting an estimated $557M.

  • 1,210 institutional investors held CVS Health (CVS) as of Q4 2013, up from 1,129 in Q3 2013.
  • Funds reported $71.4B of CVS Health stock for Q4 2013, up 22% quarter-over-quarter.
  • 157 funds opened new CVS Health positions in Q4 2013 and 65 closed out, a net change of +92 holders.
  • The largest CVS Health buyer in Q4 2013 was AllianceBernstein, an estimated $207M added.
  • The largest CVS Health seller in Q4 2013 was Fidelity Investments, an estimated $557M sold.

Based on aggregated 13F filings for Q4 2013.